SpringWorks Therapeutics Inc (SWTX)
36.30
-1.14
(-3.04%)
USD |
NASDAQ |
Nov 21, 16:00
36.60
+0.30
(+0.83%)
Pre-Market: 08:59
SpringWorks Therapeutics Profit Margin (Quarterly): -108.6% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -108.6% |
| June 30, 2024 | -66.83% |
| March 31, 2024 | -416.0% |
| December 31, 2023 | -1.73K% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 32.21% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.73K%
Minimum
Dec 2023
32.21%
Maximum
Dec 2020
-458.2%
Average
-108.6%
Median
Sep 2024
Profit Margin (Quarterly) Benchmarks
| Ocugen Inc | -1.14K% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.38% |
| Return on Assets | -44.72% |
| Return on Invested Capital | -51.38% |
| Gross Profit Margin (Quarterly) | 93.22% |
| Operating Margin (Quarterly) | -117.5% |
| Return on Net Operating Assets | -569.7% |